ZONISAMIDE — INVAGEN PHARMS, approved 2022-05-25 (ANDA077869).
10,558 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.